• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

McCarter & English Logo

  • People
  • Services
  • Insights
  • Our Firm
    • Leadership Team
    • Social Justice
    • Diversity & Inclusion
    • Pro Bono
    • Client Service Values
  • Join Us
    • Lawyers
    • Summer Associates
    • Patent Professionals
    • Professional Staff
    • Job Openings
  • Locations
    • Boston
    • Philadelphia
    • East Brunswick
    • Indianapolis
    • Stamford
    • Hartford
    • Trenton
    • Miami
    • Washington, DC
    • New York
    • Wilmington
    • Newark
  • Share

Share

Browse Alphabetically:

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
Bankruptcy, Restructuring & Litigation
Blockchain, Smart Contracts & Digital Currencies
Business Litigation
Cannabis
Coronavirus Resource Center
Corporate
Crisis Management
Cybersecurity & Data Privacy
Delaware Corporate, LLC & Partnership Law
Design, Fashion & Luxury
E-Discovery & Records Management
Energy & Utilities
Environment & Energy
Financial Institutions
Food & Beverage
Government Affairs
Government Contracts & Global Trade
Government Investigations & White Collar Defense
Healthcare
Immigration
Impact Investing
Insurance Recovery, Litigation & Counseling
Intellectual Property
Labor & Employment
Life Sciences
Manufacturing
Products Liability, Mass Torts & Consumer Class Actions
Public Finance
Real Estate
Renewable Energy
Sports & Entertainment
Tax & Employee Benefits
Technology Transactions
Transportation, Logistics & Supply Chain Management
Trusts, Estates & Private Clients
Venture Capital & Emerging Growth Companies
  • Broadcasts
  • Events
  • News
  • Publications
  • View All Insights
Search By:
Insights News Contracts Stack
Main image for USPTO Patent Guidelines Give Hope To Life Sciences Cos.
News|Quote

USPTO Patent Guidelines Give Hope To Life Sciences Cos.

Law360

5.6.2016

New U.S. Patent and Trademark Office guidance to examiners on patent eligibility may offer a lifeline to applicants seeking protection for medical diagnostic tests and other life sciences inventions, attorneys say, providing a road map for avoiding ineligibility under the Supreme Court’s Mayo and Myriad decisions.

The patent office issued a memo to examiners on Thursday instructing them to give more detailed explanations when they reject applications on subject-matter eligibility grounds. The memo was accompanied by a 31-page list of hypothetical life sciences inventions and explanations of why they are or are not patent-eligible, to which examiners can refer when evaluating applications.

“The guidance provides hope for diagnostic companies and their patent claims,” said Maria Laccotripe Zacharakis of McCarter & English LLP. “The diagnostics industry was decimated by earlier guidelines, which were largely informed by Supreme Court case law. … This new guidance means that tests to diagnose illness, or to predict how a patient will respond to a given treatment, are now eligible for patent — a potentially life-saving development for people who suffer from cancer and other dread diseases.”

“I think that the example provided here once again opens a path for life sciences and biotech companies to obtain patent protection for these very important inventions, which we have not been able to do after the Mayo and Myriad decisions,” Laccotripe Zacharakis said.

However, given the extreme difficulty in obtaining patents for diagnostic and life sciences patents since Mayo and Myriad, applicants should be encouraged by the USPTO’s examples, Laccotripe Zacharakis said.

“If you understand patent law, the distinction between Claim 1 and Claim 2 doesn’t really make sense,” she said. “But since it’s a path to patent-eligibility on these types of claims, I’m happy to take it on behalf of my clients.”

sidebar

pdfemail

Related People

Media item: Maria Laccotripe Zacharakis, PhD
Maria Laccotripe Zacharakis, PhD

Partner

Related Services

Intellectual Property
Life Sciences
Patents
Subscribe to our Insights
McCarter & English, LLP
Copyright © 2022 McCarter & English, LLP. All Rights Reserved.
  • Login
  • Attorney Advertising
  • Privacy
  • Awards Methodology
  • Contact
  • Subscribe
  • Sitemap

The McCarter & English, LLP website is for informational purposes only. We do not provide legal advice on this website. We can provide legal advice only to our clients in specific inquiries that they address to us. If you are interested in becoming a client, please contact us, but do not send any information about your specific legal question. We cannot serve as your lawyers until we establish an attorney-client relationship, which can occur only after we follow procedures within our firm and after we agree to the terms of the representation.

Accept Cancel